Watchlist Price Alert

Neuphoria Therapeutics In... (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

6.64

-0.18 (-2.58%)

At close: Jun 16, 2025, 3:59 PM

6.84

3.01%

Pre-market: Jun 17, 2025, 09:21 AM EDT

Neuphoria Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Revenue	n/a	n/a	181.36K	n/a	32.06K	2.68M	2.76M	4.13M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	181.36K	n/a	32.06K	2.68M	2.76M	4.13M
Operating Income	-17.89M	-21.56M	-14.68M	-8.96M	-6.19M	-10.76M	-21.28M	-10.8M
Interest Income	220.1K	323.16K	6.79K	4.32K	40.11K	197.95K	422.32K	925.02K
Pretax Income	-15.58M	-21.52M	-15.1M	-6.68M	-4.14M	-6.94M	-19.28M	-4.79M
Net Income	-15.49M	-21.38M	-14.97M	-6.53M	-4.89M	-6.77M	-18.43M	-5.19M
Selling & General & Admin	8.47M	8.91M	5.27M	4.24M	3.33M	6.55M	4.97M	5.72M
Research & Development	9.42M	13.07M	11.01M	4.33M	4M	6.29M	18.55M	18.61M
Other Expenses	n/a	-422.74K	-1.41M	386.74K	-1.11M	596.83K	523.58K	-9.4M
Operating Expenses	17.89M	21.56M	14.86M	8.96M	6.23M	13.43M	24.04M	14.93M
Interest Expense	n/a	14.08K	18.48K	882.32K	1.23M	1.66M	1.51M	1.51M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	17.89M	21.56M	14.86M	8.96M	6.23M	13.43M	24.04M	14.93M
Income Tax Expense	-87.32K	-139.17K	-131.95K	-140.82K	-142.65K	-165.8K	-852.96K	401.57K
Shares Outstanding (Basic)	149.8M	122.39M	112.78M	65M	45.41M	43.44M	40.19M	40.11M
Shares Outstanding (Diluted)	149.8M	122.39M	112.78M	65M	45.41M	43.44M	40.19M	40.11M
EPS (Basic)	-0.1	-0.17	-0.13	-0.1	-0.11	-0.16	-0.46	-0.13
EPS (Diluted)	-0.1	-0.17	-0.13	-0.1	-0.11	-0.16	-0.46	-0.13
EBITDA	-17.13M	-20.9M	-14.32M	-4.51M	-1.23M	-5.28M	-17.77M	-3.27M
EBIT	-17.8M	-21.56M	-15.08M	-5.79M	-2.91M	-5.28M	-17.77M	-3.27M
Depreciation & Amortization	662.99K	663.19K	763.17K	1.28M	1.68M	1.71M	1.67M	1.74M